Revenue Cycle Advisory for Endocrinology.

Why Revenue Cycle Management Is Different for Endocrinology

Endocrinology practices manage longitudinal chronic endocrine disorders—combining cognitive E/M visits with Continuous Glucose Monitoring (CGM) analysis, insulin pump management, thyroid ultrasound and fine-needle aspiration (FNA) biopsies, DXA bone density scans, and bone-health/endocrine biologic injectables.

Key coding areas include CGM sensor placement/startup and 14+ day ambulatory glucose profile interpretation (95249, 95250, 95251), ultrasound-guided thyroid FNA biopsy (10005/10006 bundles imaging guidance directly—do not bill 76942 separately), G2211 longitudinal complexity, and Prolia/Evenity/Reclast J-code injectables.

• Key coding areas include CGM sensor placement/startup and 14+ day ambulatory glucose profile interpretation (95249, 95250, 95251), ultrasound-guided thyroid FNA biopsy (10005/10006 bundles imaging guidance directly—do not bill 76942 separately), G2211 longitudinal complexity, and Prolia/Evenity/Reclast J-code injectables.
• Alignment with CMS National Correct Coding Initiative (NCCI) PTP edits, MUE unit caps, and regional MAC Local Coverage Determinations (LCDs)
• Pre-bill verification of prior authorization numbers, rendering provider credentials, and site-of-service differentials
• Contractual fee-schedule modeling to catch commercial and Medicare Advantage underpayments at 835ERA posting

Prior Authorization, Medical Necessity & Denial Patterns in Endocrinology

GLP-1/GIP therapies, CGM supplies, insulin pumps, and osteoporosis biologics require intensive prior authorization workflows, while frequent CGM interpretations (95251) must obey monthly frequency limits.

Endocrinology groups lose revenue by under-coding complex Level 4 (99214) visits, failing to bill 95251 CGM interpretations or G2211 add-ons, NCCI bundling denials on thyroid ultrasound + FNA, and J-code unit/wastage errors.

• Front-end eligibility and benefit verification tied directly to scheduled CPT/HCPCS procedure codes and site-of-service POS indicators
• Automated tracking of payer-specific prior authorization validity windows, unit thresholds, and peer-to-peer clinical escalation timelines
• Root-cause categorization of CARC 50 (medical necessity), CARC 97 (bundling/inclusive service), CARC 197 (missing precertification), and CARC 4/16 (modifier/claim data errors)
• Contractual underpayment variance auditing against Medicare Physician Fee Schedule (MPFS), ASC payment rates, and commercial payer fee schedules

Important KPIs, Benchmarks & A/R Economics for Endocrinology Groups

For endocrinology organizations between $5M and $100M+ in net patient revenue, eliminating specialty coding friction, prior authorization write-offs, and silent payer underpayments directly improves cash velocity and operating EBITDA.

Automating CGM interpretation charge capture from cloud device portals (Dexcom Clarity, LibreView, Glooko) and standardizing thyroid FNA coding templates in the EHR directly improves net revenue per visit.

In-House vs. Outsourced Endocrinology Billing: What to Evaluate in an RCM Partner

Deciding whether to run endocrinology billing internally, operate a hybrid model, or outsource to a specialty RCM company requires looking past headline percentage fees. A billing vendor charging 4% that leaves 6% of net collectible revenue on the table through unappealed CARC 97/50 denials or unworked >90-day A/R costs far more than a disciplined internal or specialty-calibrated operation.

RCM Advisory Partners helps organizations benchmark their current operation before negotiating with vendors, and structures rigorous evaluation criteria when an external partner is warranted.

• Encounter-to-claim charge capture reconciliation across all endocrinology service locations
• Specialty CPT, HCPCS, ICD-10-CM, and modifier accuracy audit for endocrinology
• Prior authorization intake, medical-necessity documentation, and CARC 197/50 denial prevention
• Line-level payer allowable reconciliation and aged >90-day A/R recovery workflow review
• Verify certified coder proficiency in endocrinology CPT/HCPCS hierarchies, NCCI bundling edits, and Medicare LCDs
• Audit true net collection yield against contracted endocrinology fee schedules rather than blended gross adjustments
• Require transparent workqueue visibility on >60 and >90 day A/R and clinical appeal overturn rates

30/60/90-Day Endocrinology Revenue Cycle Diagnostic & Optimization Plan

Our advisory engagements translate endocrinology claim and remittance data into a prioritized 90-day execution roadmap:

1. 01
   Days 1–30: Specialty Claim Audit, Coding Review & Fee Schedule Reconciliation

   Audit a statistically valid sample of paid, denied, and zero-pay endocrinology claims across top commercial and Medicare payers; benchmark CPT/modifier distribution and identify immediate underpayment and denial recovery opportunities.

2. 02
   Days 31–60: Prior Authorization, Scrubber Edit & EHR Template Remediation

   Reconfigure front-end authorization matrices, clinical documentation templates, and clearinghouse NCCI/LCD pre-bill edits to stop preventable denials before 837 submission.

3. 03
   Days 61–90: Aged A/R Recovery, Payer Escalation & Vendor SLA Governance

   Deploy structured appeal playbooks for high-value surgical, diagnostic, or infusion claims, and establish monthly KPI scorecards holding internal leads or external billing partners accountable.